Overview
Ludmila Martin is an Oncologist in Puyallup, Washington. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Neuroendocrine Tumor. Dr. Martin is currently accepting new patients.
Her clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Accepted plan types not found. Please verify directly with the provider.
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- PPO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Puyallup, WA 98373
Additional Areas of Focus
Dr. Martin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Association Of University Physicians
Michael Schweizer is an Oncologist in Seattle, Washington. Dr. Schweizer is rated as a Distinguished provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Hormone Replacement Therapy (HRT), and Orchiectomy. Dr. Schweizer is currently accepting new patients.
St. Michael Cancer Center
Jacob Mathew, MD is a fellowship trained, board-certified hematologist/oncologist who believes we are born with essential dignity and his goal is to preserve that dignity, at times using his medical knowledge and at other times just being there for his fellow man. Dr. Mathew believes that the practice of medicine should be evidence-based while simultaneously incorporating the art of medicine. To him, the art of medicine means he needs to be the advocate for his patients. He also hopes to empower his patients to play a pivotal role in their medical care and decision making by teaching them at least the basics of their disease. Dr. Mathew is rated as a Distinguished provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Pleuropulmonary Blastoma, Osteotomy, and Bone Marrow Aspiration.
Virginia Mason Medical Center
John Paul Flores, MD, is a board-certified medical oncologist. He cares for patients with blood disorders and all forms of cancer.Dr. Flores takes the time to guide his patients on their wellness journey, listening to what they say, answering their questions and providing a path forward with hope. In this complex, fast-growing field where new treatments are approved for clinical use regularly, Dr. Flores relies on the expertise of a team of surgeons, pathologists, radiation oncologists and other colleagues to stay at the forefront of cancer treatment and to provide comprehensive, patient-centered care. Dr. Flores is rated as a Distinguished provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Clear Cell Sarcoma, Prostatectomy, and Splenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AgranulocytosisDr. Martin isDistinguished. Learn about Agranulocytosis.
- Chronic Familial NeutropeniaDr. Martin isDistinguished. Learn about Chronic Familial Neutropenia.
- Colorectal CancerDr. Martin isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Martin isDistinguished. Learn about Familial Colorectal Cancer.
- Hemangioma Thrombocytopenia SyndromeDr. Martin isDistinguished. Learn about Hemangioma Thrombocytopenia Syndrome.
- Lung CancerDr. Martin isDistinguished. Learn about Lung Cancer.
- Advanced
- Ampullary CancerDr. Martin isAdvanced. Learn about Ampullary Cancer.
- Anal CancerDr. Martin isAdvanced. Learn about Anal Cancer.
- AngiosarcomaDr. Martin isAdvanced. Learn about Angiosarcoma.
- Appendix CancerDr. Martin isAdvanced. Learn about Appendix Cancer.
- Breast CancerDr. Martin isAdvanced. Learn about Breast Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Martin isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Martin isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Martin isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Martin isExperienced. Learn about Acute Promyelocytic Leukemia.